Financial incentive: Difference between revisions

Line 197:

== Profit from harvested foreskins ==

Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic skin, and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref name="hodges1997" /> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at {{UNI|Boston University|BU}} [http://www.bumc.bu.edu/ School of Medicine], insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref>

Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic [[skin]], and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref name="hodges1997" /> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at {{UNI|Boston University|BU}} [http://www.bumc.bu.edu/ School of Medicine], insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref>

=== Corporate benefactors ===

Line 204:

* [[Advanced Tissue Sciences]] (ATS) <ref>Forget pork bellies, now it's foreskins. Manson B. ''San Diego Reader'' (May 4, 1995): 12, 14 passim.</ref>

* [[Organogenesis]]<ref>New skin twin life- and look-save. Brewer S. ''Longevity'' (September 1992): 18.</ref>

* BioSurface Technology<ref>Companies see $1.5b market in replacement skin products. Rosenberg R. ''Boston Globe'' (October 19, 1992): 22-23.</ref>

* BioSurface Technology<ref>Companies see $1.5b market in replacement [[skin]] products. Rosenberg R. ''Boston Globe'' (October 19, 1992): 22-23.</ref>

* Genzyme

* Ortec International

@@ Line 197: / Line 197: @@
 == Profit from harvested foreskins ==
-Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic skin, and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref name="hodges1997" /> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at {{UNI|Boston University|BU}} [http://www.bumc.bu.edu/ School of Medicine], insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref>
+Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic [[skin]], and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref name="hodges1997" /> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at {{UNI|Boston University|BU}} [http://www.bumc.bu.edu/ School of Medicine], insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref>
 === Corporate benefactors ===
@@ Line 204: / Line 204: @@
 * [[Advanced Tissue Sciences]] (ATS) <ref>Forget pork bellies, now it's foreskins. Manson B. ''San Diego Reader'' (May 4, 1995): 12, 14 passim.</ref>
 * [[Organogenesis]]<ref>New skin twin life- and look-save. Brewer S. ''Longevity'' (September 1992): 18.</ref>
-* BioSurface Technology<ref>Companies see $1.5b market in replacement skin products. Rosenberg R. ''Boston Globe'' (October 19, 1992): 22-23.</ref>
+* BioSurface Technology<ref>Companies see $1.5b market in replacement [[skin]] products. Rosenberg R. ''Boston Globe'' (October 19, 1992): 22-23.</ref>
 * Genzyme
 * Ortec International